Company news

Bioretec Ltd. news in 2025

Bioretec Ltd.'s news releases, calls and decks from 2025, newest first.

View company

Bioretec Ltd's schedule for financial reporting and Annual General Meeting in 2026

December 22, 2025

Inside information: Bioretec updates its strategy for 2026-2028 and provides new financial targets

December 16, 2025

Inside information: Bioretec has been granted FDA Breakthrough Device Designation status for its RemeOs™ DrillPin

December 14, 2025

Change negotiations completed at Bioretec

December 4, 2025

Bioretec Ltd's business review January-September 2025: Strengthening commercial foundations and strategy design

November 13, 2025

Inside information: Bioretec initiates change negotiations to enhance operational efficiency and competitiveness

November 12, 2025

Correction: Bioretec Ltd's Half-year report 2025

October 31, 2025

Inside information: Bioretec adjusts and restates previously reported net sales FOR H1/2025 and does not expect accelerated sales in 2025

October 27, 2025

Inside information: Bioretec is revising its financial targets, deems that the current financial targets will not be met and withdraws its financial targets

October 27, 2025

Bioretec's RemeOs™ Screw LAG Solid Receives CMS Transitional Pass-Through Payment in the US

October 1, 2025

Bioretec Appoints Dr. Christopher W. DiGiovanni to Scientific Advisory Board

September 4, 2025

Bioretec Appoints Jordy Winters as Vice President of OUS Sales to Accelerate International Growth

September 2, 2025

Bioretec Appoints Sarah van Hellenberg Hubar-Fisher as Chief Executive Officer

August 27, 2025

Bioretec Ltd's Half-year report 2025: Strong support for future growth from a successful rights issue

August 14, 2025

Bioretec Ltd adjusts the terms and conditions of its stock option programs due to the completed rights issue

June 27, 2025

Final results of Bioretec Ltd's successful rights issue

June 24, 2025

Inside information: Preliminary result of Bioretec Oy's rights issue

June 23, 2025

Inside information: Bioretec Ltd's Board of Directors resolved on a rights issue of approximately EUR 9.2 million and publishes the terms and conditions of the fully guaranteed rights issue

May 28, 2025

New shares of Bioretec Ltd subscribed with option rights have been registered with the trade register

May 20, 2025

Inside information: Sarah van Hellenberg Hubar-Fisher appointed interim CEO of Bioretec

May 15, 2025

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

May 15, 2025

Inside information: Bioretec´s CEO Alan Donze to resign

May 8, 2025

Decks in 2025